Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23192920 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
Condition: Peripheral Arterial Disease
Interventions: Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion
2 Completed Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Conditions: Peripheral Artery Disease;   Peripheral Vascular Disease;   Critical Limb Ischemia
Interventions: Biological: CD34-positive cells;   Biological: Saline and 5% autologous plasma

Indicates status has not been verified in more than two years